What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...
On "The Friday Brief," coming back from the July 4th holiday, no shortage of pharma wheelings and dealings to begin July.
As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...
Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing, dual sourcing and networked CDMO capacity ...